Upcoming Webinars

Tube Transition Tips: Moving to breastfeeding and oral feeding in the NICU

Time to read: 1 min.

Speaker: Dr. Rebecca Hoban

Date/time: August 4th 1pm CST

Overview:

This seminar will provide evidence and pragmatic tips on the NICU transition that’s on the forefront of every parent’s mind: when will my baby eat by mouth so they can go home? We’ll discuss getting baby to breast in the NICU, giving clinicians the tools to fight the common NICU mantra that babies can go home and “work on breastfeeding later.” Learn how to support parents’ breastfeeding goals while in the NICU to set them up for success after discharge!

Objectives:

Goals and expectations for transitioning off NG/OG feeds
Evidence for direct breastfeeding in the NICU and relationship to long-term lactation success
Common questions about the transition to breastfeeding, like "Is my baby getting enough?” “What about Nipple confusion?” and “How do I breastfeed on fortified feeds?"

Speaker

Rebecca Hoban, MD, MPH

Dr. Rebecca Hoban is a board certified neonatologist with a strong clinical, research, and educational interest in human milk and lactation. Dr. Hoban graduated from Indiana University School of Medicine and completed pediatric residency at Cincinnati Children’s, neonatology fellowship at Tufts Floating Hospital Boston, and a masters in public health at Harvard. She has held positions as a staff neonatologist at Rush University Medical Center in Chicago and the Hospital for Sick Children/University of Toronto in Canada, before moving back to the US in 2023 to become Director of Breastfeeding Medicine for the Division of Neonatology at Seattle Children’s Hospital and the University of Washington. She brings extensive clinical, educational, and training experiences from a dozen countries and is active in clinical and translational human milk research. Recent research and clinical projects include improving human milk provision in the high-risk neonatal population, milk sodium and biomarkers to predict lactation success, lactation in the context of substance use, and human milk as potential stem cell therapy in preterm infants with intraventricular hemorrhage.